Access
This article is part of Nature's premium content.
Please note this is News in Brief, and so will be a short article.
Published online 13 August 2008 | Nature | doi:10.1038/454815c
San Francisco's biotech hub gets lift from Pfizer deal
To read this story in full you will need to login or make a payment (see right).
Please note this is News in Brief, and so will be a short article.
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
